Picture of Abbvie logo

ABBV Abbvie Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Annual cashflow statement for Abbvie, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line7,8824,62211,54911,8454,873
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items4,7548,7144,9276,8209,344
Extraordinary Items
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1,329106-1,322-2582,813
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Cash from Operating Activities13,32417,58822,77724,94322,839
Capital Expenditures-552-798-787-695-777
Purchase of Fixed Assets
Other Investing Cash Flow Items1,148-36,759-1,55772-1,232
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities596-37,557-2,344-623-2,009
Financing Cash Flow Items-552-333-674-1,102-742
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities18,708-11,501-19,039-24,803-17,222
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash32,635-31,4751,297-5453,613